OOIR: Observatory of International Research

Papers

(The TQCC of Current Opinion in Allergy and Clinical Immunology is 8. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-05-01 to 2026-05-01.)

Article	Citations
What molecular allergy teaches us about genetics and epidemiology of allergies	57
The pathogenetic role of Th17 immune response in atopic dermatitis	27
The use of environmental exposure chambers in studies related to ocular surface effects	24
The collaborative medical practice of the ocular surface: a major role of the allergist/immunologist	21
Anaphylaxis due to antiallergic and antiasthmatic biologics	19
Liver disease in primary antibody deficiencies	19
Economic burden of drug-induced anaphylaxis: what can we do better?	18
E-cigarettes and asthma in adolescents	18
Is immunotherapy safe for treatment of severe asthma	18
Drug allergy awareness and perspectives with the implementation of the International Classification of Diseases-11	18
Update on occupational allergy, including asthma, to soluble platinum salts	17
Atopic manifestations of inborn errors of immunity	17
Consequences of severe asthma exacerbations	17
Bronchiectasis and obstructive lung diseases in primary antibody deficiencies and beyond: update on management and pathomechanisms	17
Chronic spontaneous urticaria: new evidences on the role of autoimmunity	17
New approaches in childhood asthma treatment	17
Editorial introductions	15
Real-world evidence of allergen immunotherapy	15
Neuroimmune signalling pathways in chronic rhinosinusitis with nasal polyps	15
Editorial introductions	15
Mast cell conditions and drug allergy: when to suspect and how to manage	15
Ocular involvement in allergic drug reactions	14
Epidemiology of the relationship between allergic bronchopulmonary aspergillosis and asthma	13
Paucity of gastrointestinal plasma cells in common variable immunodeficiency	13
Perioperative anaphylaxis: when the allergological work-up goes negative	13

Transition of care in inborn errors of immunity	13
Editorial introductions	12
LNIT-Local nasal immunotherapy in allergic rhinitis: revisited evidence and perspectives	12
Updates in diagnosis and management of paediatric mastocytosis	12
A review of food allergy-related costs with consideration to clinical and demographic factors	12
Is allergen immunotherapy a model of personalized treatment in pediatric respiratory allergy?	12
Editorial introductions	12
Management and treatment of perioperative hypersensitivity	11
Updates in school-based asthma management	11
Food-labeling issues for severe food-allergic consumers	11
Health disparities in allergic diseases	11
Greater mechanistic understanding of the cutaneous pathogenesis of Stevens–Johnson syndrome/toxic epidermal necrolysis can shed light on novel therapeutic strategies: a comprehensive review	11
Chronic rhinosinusitis with nasal polyps: eosinophils versus B lymphocytes in disease pathogenesis	10
Role of the ocular surface microbiome in allergic eye diseases	10
Clinical remission in severe asthma: lights and shadows on an ambitious goal	10
Editorial introductions	10
Monogenic forms of common variable immunodeficiency and implications on target therapeutic approaches	10
The complexity in DNA methylation analysis of allergic diseases	10
What's new in pediatric asthma and rhinitis phenotypes and endotypes?	9
Update on hereditary C1q deficiency: pathophysiology, clinical presentation, genotype and management	9
Strengthening the case for intralymphatic immunotherapy	9
Food allergy: new therapeutic options open deeper questions	9
Precision allergy molecular diagnosis applications in food allergy	9
Do bacterial vaccines/adjuvants prevent wheezing episodes in children?	9
Biomarkers in the diagnosis of mast cell activation	9
Pathology of T-cell-mediated drug hypersensitivity reactions and impact of tolerance mechanisms on patient susceptibility	8
Occupational respiratory allergy to reactive dyes	8
Precision medicine to personalize medicine in allergic airway disease	8
Access from healthcare professionals to evidence-based pharmacotherapy in allergy management	8
Immunobiologicals and ocular surface disease	8
Poor statistical reporting: do we have a reason for concern? A narrative review and recommendations	8
Predictive models and applicability of artificial intelligence-based approaches in drug allergy	8
Atopic dermatitis and ocular allergy: common mechanisms and uncommon questions	8
Interstitial lung diseases in inborn errors of immunity	8
Giant cell arteritis and innovative treatments	8
The role of macrolides in chronic rhinosinusitis and nasal polyps	8
New causes of occupational allergic contact dermatitis	8
Neurotrophic keratitis: inflammatory pathogenesis and novel therapies	8
Adverse effects of anti-cancer biologics on the ocular surface	8